ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,509.01
      0.62%
      US Tech 100
      19,460.00
      0.95%
      Dow Jones
      39,331.85
      0.41%
      Brent Oil
      86.46
      0.02%
      Bitcoin
      61,377.68
      -1.05%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Cartesian Therapeutics Inc (RNAC) Quote

      Cartesian Therapeutics Inc

      Cartesian Therapeutics Inc (RNAC)

      NASDAQ
      15.77
      -8.50
      (-35.02%)
      Closed July 02 4:00PM
      Delayed by 15 minutes
      16.25
      0.48
      (3.04%)
      After Hours: 6:51PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      16.25
      Bid
      15.90
      Ask
      16.24
      Volume
      1,449,046
      15.53 Day's Range 19.4177
      11.665 52 Week Range 42.60
      Market Cap
      280.644M
      Previous Close
      24.27
      Open
      17.97
      Last Trade
      3
      @
      16.24
      Last Trade Time
      Financial Volume
      $ 24,479,667
      VWAP
      16.8936
      Average Volume (3m)
      106,667
      Shares Outstanding
      17,796,053
      Dividend Yield
      -
      PE Ratio
      -1.28
      Earnings Per Share (EPS)
      -12.35
      Revenue
      26M
      Net Profit
      -219.71M

      About Cartesian Therapeutics Inc

      Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL... Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.selectabio.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Cartesian Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RNAC. The last closing price for Cartesian Therapeutics was $24.27. Over the last year, Cartesian Therapeutics shares have traded in a share price range of $ 11.665 to $ 42.60.

      Cartesian Therapeutics currently has 17,796,053 shares outstanding. The market capitalization of Cartesian Therapeutics is $280.64 million. Cartesian Therapeutics has a price to earnings ratio (PE ratio) of -1.28.

      RNAC Latest News

      More News

      Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik

      GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for...

      6 hours ago
      GlobeNewswire Inc.

      FeaturedBNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth

      15 hours ago

      Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing

      GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for...

      16 hours ago
      GlobeNewswire Inc.

      Cartesian Therapeutics Announces Positive Topline Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis

      Trial met primary endpoint with statistical significance, with 71% of myasthenia gravis patients treated with Descartes-08 observed to have a clinically meaningful improvement in MGC score at...

      16 hours ago
      GlobeNewswire Inc.

      Cartesian Therapeutics Announces New Employment Inducement Grant

      GAITHERSBURG, Md., June 06, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the...

      June 06 2024
      GlobeNewswire Inc.

      Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis

      GAITHERSBURG, Md., May 22, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for...

      May 22 2024
      GlobeNewswire Inc.

      Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

      GAITHERSBURG, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the “Company), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune...

      May 13 2024
      GlobeNewswire Inc.

      Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

      Topline data from Phase 2b trial of Descartes-08, the Company’s potential first-in-class mRNA CAR-T cell therapy, in myasthenia gravis on track for mid-2024 On track to dose first patient in Phase...

      May 08 2024
      GlobeNewswire Inc.

      Cartesian Therapeutics Announces New Employment Inducement Grants

      Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune diseases, today announced the...

      May 06 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-6.63-28.977272727322.8829.6515.5318451226.67400288CS
      4-19.98-55.147667678736.2341.8715.5311943227.3266639CS
      123.7329.792332268412.5241.8712.5210666724.75450996CS
      26-4.45-21.497584541120.741.8711.66541229820.9476476CS
      52-7.945-32.837363091524.19542.611.66556160023.59625602CS
      156-7.945-32.837363091524.19542.611.66556160023.59625602CS
      260-7.945-32.837363091524.19542.611.66556160023.59625602CS

      Market Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      RDZNRoadzen Inc
      $ 2.95
      (82.10%)
      		107.99M
      SYTSYLA Technologies Company Ltd
      $ 3.05
      (59.69%)
      		6.19M
      VSVersus Systems Inc
      $ 1.90
      (43.94%)
      		58.92M
      VIVKVivakor Inc
      $ 3.41
      (36.95%)
      		727.57k
      MEDSTRxADE HEALTH Inc
      $ 18.585
      (30.70%)
      		397.65k
      MAXNMaxeon Solar Technologies Ltd
      $ 0.18
      (-67.20%)
      		173.82M
      RNACCartesian Therapeutics Inc
      $ 15.7715
      (-35.02%)
      		1.45M
      EFTReFFECTOR Therapeutics Inc
      $ 0.18
      (-32.56%)
      		1.63M
      DTSSDatasea Inc
      $ 3.43
      (-30.57%)
      		1.15M
      ARDXArdelyx Inc
      $ 5.29
      (-30.12%)
      		22.67M
      NVDANVIDIA Corporation
      $ 122.67
      (-1.31%)
      		220.35M
      TSLATesla Inc
      $ 231.26
      (10.20%)
      		205.03M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.18
      (-67.20%)
      		173.82M
      SQQQProShares UltraPro Short QQQ
      $ 7.88
      (-2.96%)
      		114.55M
      RDZNRoadzen Inc
      $ 2.95
      (82.10%)
      		107.99M

      Discussion

      View Full Feed
      CrossFireTrader CrossFireTrader 4 minutes ago
      No that’ll be the 20th….maybe. If Melvin stays true yo form the 21st or 22nd
      GDVM
      jonestint jonestint 4 minutes ago
      Ah! I have a new buddy to watch! Hahahahaha!!!! I love these boards with posters who are down so far in the red. Your chart here looks worse than Clean Scam! That's hysterical!
      IGEX
      dloggold dloggold 4 minutes ago
      hey good luck to you maybe you were more shrewd than the shrewdest of shrewdness.
      HGENQ
      Humbert Humbert 6 minutes ago
      The stock should settle at a much higher price as the merger is confirmed and details are released.
      BNCM
      caddiedad caddiedad 7 minutes ago
      Dancing, if someone completely new to Amarin and the EPA molecule were to read all the positive comments from your post below there would be tripping over one another and a mad rush to invest in this potential blockbuster drug with all sorts of medical benefits, yet here we are under cash value. Bey
      AMRN
      demonsmith demonsmith 7 minutes ago
      I'm sure ceo already bought that note like he did couple weeks ago
      SMCE
      Namtro Namtro 8 minutes ago
      You are spot on!
      NSAV
      nilremerlin nilremerlin 8 minutes ago
      https://mjbizdaily.com/cannabis-operators-vow-to-take-federal-prohibition-challenge-to-supreme-court/
      AYRWF
      DR_rugby DR_rugby 8 minutes ago
      DTCC obligation warehouse
      Changes coming soon
      2 Aug 2024

      https://www.dtcc.com/-/media/Files/pdf/2024/6/27/OWOCCTFT1.pdf

      Check it out

      GLTA
      GME
      DTGoody DTGoody 9 minutes ago
      Actually, I took their money! LOL I was actively day trading this when it was on the NASDAQ. I Made plenty of money! I seen the writing on the wall when they were pushing the vaccines, and I knew they weren't going to approve LENS, so I excited my position before the FDA News came out.
      HGENQ
      Zorax Zorax 9 minutes ago
      Yes. And I'm relieved you noticed coming from someone people on here respect.
      NorfolkIP NorfolkIP 11 minutes ago
      The most predictable response. Continued inability to provide proof or evidence of your claims make you insufferable and a fraud. ✌🏽
      IGEX
      JamesF1 JamesF1 12 minutes ago
      HGilS, thank you for the transcript.
      ELTP
      demonsmith demonsmith 13 minutes ago
      Were going to test 0.01 tomorrow
      SMCE
      MrPuff MrPuff 13 minutes ago
      This won't slow us down much. SS still gonna be looking good.

      https://x.com/TheStockGuru13/status/1808317123015668097
      SMCE
      DesertDrifter DesertDrifter 13 minutes ago
      I have been pretty busy lately and haven't watched much tube for a month or so. I had CNN on today while I did some chores, and they were beating on biden for an hour straight without so much of a mention of trump's incoherent dementia. Now we have TWO Fox networks?
      pdgood pdgood 14 minutes ago
      Like the 99 cent buy at close

      so they dont have ta look at .0009 all night?
      900 x .0011= .99
      PRETEND LAND is just friggin classic. ASK RHODEHAMEL
      He brew this fraud
      BLLB
      DesertDrifter DesertDrifter 15 minutes ago
      "So, Biden "COULD" arrest Trump and put him in jail for taking classified documents and cite that Trump is a national security risk and call it an official act and it be ok according to the Supreme Court." - Matt Walton

      The situation is, however, that Biden is an honorable man and wou
      TaperT2 TaperT2 16 minutes ago
      Good Call ….i didnt listen
      IREN
      The GidDy uP Kid The GidDy uP Kid 16 minutes ago
      NLSP… Inverted HammeR…
      https://schrts.co/rMtDQnGs
      NLSP
      JessieB JessieB 16 minutes ago
      I agree with you - I just don't like the fact that there are believers and they are losing money listening to these scammers... and perhaps they cannot afford to lose any money! Especially now! I wish you well and GOOD LUCK in whatever you do!
      BEGI
      The GidDy uP Kid The GidDy uP Kid 16 minutes ago
      NLSP… Inverted HammeR…
      https://schrts.co/rMtDQnGs
      NLSP
      LittleBirdin my Ear LittleBirdin my Ear 17 minutes ago
      Good news soon ....
      SFRX

      Your Recent History

      NASDAQ
      RNAC
      Cartesian Therapeutics
      TSX
      PRQ
      Petrus Resources
      Delayed Upgrade Clock